Product image of Meropenem Noridem (Meropenem) supplied by GNH India

Meropenem Noridem

Active Ingredient:
Meropenem
Origin:
EU

Meropenem Noridem (Meropenem)

Meropenem, the active ingredient in Meropenem Noridem, is a carbapenem antibiotic presented as an injectable for intravenous use. It treats a range of serious bacterial infections in hospitalized patients, including intra‑abdominal, urinary, respiratory, and central nervous system infections.
GNH India supplies Meropenem Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Noridem Enterprises Ltd

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Meropenem is a broad‑spectrum carbapenem used for severe bacterial infections across several organ systems.
  • Complicated intra‑abdominal infections: provides bactericidal activity to eradicate mixed aerobic and anaerobic pathogens.
  • Complicated urinary tract infections: eliminates resistant Gram‑negative organisms causing pyelonephritis and cystitis.
  • Hospital‑acquired pneumonia: treats multidrug‑resistant pathogens in ventilated patients.
  • Ventilator‑associated pneumonia: offers effective coverage against Pseudomonas and Acinetobacter species.
  • Meningitis: penetrates the cerebrospinal fluid to eradicate causative bacteria.
  • Severe sepsis: delivers rapid bacterial kill in systemic infections.

How It Works

  • Meropenem binds to penicillin‑binding proteins (PBPs) on bacterial cell walls, inhibiting the final transpeptidation step of peptidoglycan synthesis. This disruption weakens the cell wall, leading to osmotic lysis and bactericidal activity against a wide range of Gram‑positive, Gram‑negative, and anaerobic organisms.

Side Effects

Adverse reactions may occur with meropenem therapy.

Common Side Effects

  • Nausea or vomiting: gastrointestinal discomfort during treatment.
  • Diarrhea: may be mild to moderate, occasionally leading to dehydration.
  • Infusion site phlebitis: redness or pain at the intravenous site.
  • Elevated liver enzymes: transient increase in ALT/AST.
  • Headache: mild to moderate intensity.

Serious or Rare Side Effects

  • Seizures: especially in patients with CNS disorders or renal impairment.
  • Clostridioides difficile‑associated colitis: severe diarrhea requiring medical attention.
  • Anaphylaxis: acute hypersensitivity reaction with rash, bronchospasm, or hypotension.
  • Severe neutropenia: marked reduction in white blood cells increasing infection risk.
  • Renal impairment: acute kidney injury potentially requiring dose adjustment.

Precautions & Warnings

  • Clinicians should consider several safety measures before and during meropenem therapy.
  • Renal function monitoring: adjust dose in patients with reduced creatinine clearance.
  • Seizure risk assessment: avoid or monitor in patients with a history of epilepsy or CNS disease.
  • Hypersensitivity screening: do not use in individuals with known carbapenem or beta‑lactam allergy.
  • Pregnancy and lactation caution: weigh benefits against potential fetal or infant risks.
  • Liver function monitoring: check transaminases during prolonged therapy.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Avoid Interactions

Meropenem may interact with other medicines, requiring attention to dosage or monitoring.

Major Interactions (Avoid)

  • Valproic acid: meropenem reduces serum levels, increasing seizure risk.
  • Probenecid: may increase meropenem plasma concentrations, raising toxicity potential.
  • Aminoglycosides: concurrent use can enhance nephrotoxicity.

Moderate Interactions (Monitor Closely)

  • Warfarin: may alter INR, requiring more frequent coagulation monitoring.
  • Diuretics: affect renal clearance, necessitating dose review.
  • Oral contraceptives: possible reduction in efficacy, advise additional contraceptive measures.

Frequently Asked Questions

Meropenem Noridem is indicated for serious bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, hospital‑acquired and ventilator‑associated pneumonia, meningitis, and severe sepsis. It is typically reserved for patients in hospital settings where resistant organisms are suspected.

Meropenem inhibits bacterial cell wall synthesis by binding to penicillin‑binding proteins. This blocks the cross‑linking of peptidoglycan strands, weakening the cell wall and causing bacterial lysis. Its broad spectrum covers many Gram‑positive, Gram‑negative, and anaerobic pathogens.

The dosage of Meropenem Noridem is determined by the prescribing clinician based on infection severity, site, and patient renal function. Dosing regimens are individualized and should follow local antimicrobial stewardship guidelines.

Safety data for meropenem in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and under close medical supervision.

To request Meropenem Noridem, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Meropenem shares a similar spectrum with imipenem and ertapenem but offers greater stability against certain beta‑lactamases and a broader Gram‑negative coverage, including Pseudomonas. It is often preferred for severe infections where high tissue penetration and rapid bactericidal activity are required.

Meropenem Noridem should be stored refrigerated at 2‑8 °C, protected from light, and must not be frozen. Once reconstituted, the solution should be used within the time frame specified in the product labeling and kept at controlled room temperature if required.

Meropenem Noridem is given by intravenous infusion. The infusion rate and duration are set by the healthcare professional, typically over 15‑30 minutes, and may be repeated every 8 hours depending on the infection and renal function.

Serious risks include seizures, especially in patients with pre‑existing CNS disorders or renal impairment, severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, and significant renal toxicity when combined with other nephrotoxic agents.

Patients with a known hypersensitivity to meropenem, other carbapenems, or any beta‑lactam antibiotics should avoid this drug. Caution is also advised for individuals with severe renal impairment, a history of seizures, or those receiving interacting medications without appropriate monitoring.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Meropenem

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT